Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
DTWD1 pseudogene 2 (DTWD1P2) is a pseudogene related to the DTWD1 gene, which encodes a tRNA-uridine aminocarboxypropyltransferase involved in tRNA modification[5]. As a pseudogene, DTWD1P2 does not code for a functional protein product and is not recognized as a molecular target for approved medications or experimental drugs. Pseudogenes like DTWD1P2 are generally considered biologically inactive, though some may exert regulatory effects on their parental genes or other targets through RNA-based mechanisms; there is no evidence DTWD1P2 has such roles[2][4][6]. DTWD1P2 is thus not a therapeutic target, nor is it reported to have clinical or biomarker utility.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on DTWD1 pseudogene 2 (DTWD1P2).